Repligen Accounts Payable vs Property Plant And Equipment Gross Analysis

RGEN Stock

USD 146.92 0.75 0.51%

Repligen financial indicator trend analysis is much more than just breaking down Repligen prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Repligen is a good investment. Please check the relationship between Repligen Accounts Payable and its Property Plant And Equipment Gross accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

Accounts Payable vs Property Plant And Equipment Gross

Accounts Payable vs Property Plant And Equipment Gross Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Repligen Accounts Payable account and Property Plant And Equipment Gross. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Repligen's Accounts Payable and Property Plant And Equipment Gross is 0.81. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Property Plant And Equipment Gross in the same time period over historical financial statements of Repligen, assuming nothing else is changed. The correlation between historical values of Repligen's Accounts Payable and Property Plant And Equipment Gross is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Repligen are associated (or correlated) with its Property Plant And Equipment Gross. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Gross has no effect on the direction of Accounts Payable i.e., Repligen's Accounts Payable and Property Plant And Equipment Gross go up and down completely randomly.

Correlation Coefficient

0.81

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Repligen obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Repligen are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Property Plant And Equipment Gross

Most indicators from Repligen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Repligen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.At this time, Repligen's Selling General Administrative is very stable compared to the past year. As of the 17th of February 2025, Enterprise Value Over EBITDA is likely to grow to 94.31, while Tax Provision is likely to drop about 7.4 M.

	2022	2023	2024	2025 (projected)
Gross Profit	455.7M	284.2M	308.8M	533.9M
Total Revenue	801.5M	638.8M	632.4M	766.2M

Gross Profit Total Revenue

Repligen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Accounts Payable	Short Term Debt	Other Assets	Common Stock Total Equity	Short Term Investments
Total Assets		0.92	0.94	0.76	0.84	0.95	-0.29	0.93	0.96	0.98	0.48	0.97	0.98	0.86	0.84	0.96	0.96	0.93	0.98	0.94	0.99	0.88	0.41	0.38	0.8	0.05
Short Long Term Debt Total	0.92		0.81	0.51	0.93	0.96	-0.01	0.96	0.91	0.92	0.63	0.91	0.94	0.83	0.97	0.92	0.95	0.87	0.97	0.97	0.91	0.73	0.16	0.29	0.66	-0.08
Other Current Liab	0.94	0.81		0.87	0.77	0.9	-0.34	0.85	0.88	0.94	0.41	0.9	0.95	0.86	0.7	0.95	0.89	0.91	0.91	0.88	0.94	0.98	0.61	0.26	0.81	0.16
Total Current Liabilities	0.76	0.51	0.87		0.45	0.66	-0.54	0.63	0.7	0.76	0.13	0.73	0.75	0.7	0.32	0.77	0.7	0.78	0.67	0.63	0.78	0.9	0.86	0.17	0.75	0.32
Total Stockholder Equity	0.84	0.93	0.77	0.45		0.9	0.1	0.88	0.8	0.84	0.61	0.79	0.89	0.71	0.91	0.85	0.93	0.82	0.9	0.91	0.8	0.73	0.13	0.29	0.54	-0.23
Property Plant And Equipment Net	0.95	0.96	0.9	0.66	0.9		-0.01	0.99	0.89	0.96	0.57	0.9	0.98	0.82	0.9	0.99	0.96	0.91	0.98	1.0	0.93	0.84	0.33	0.29	0.7	0.13
Net Debt	-0.29	-0.01	-0.34	-0.54	0.1	-0.01		0.02	-0.4	-0.25	0.18	-0.39	-0.18	-0.36	0.11	-0.11	-0.16	-0.25	-0.15	0.04	-0.37	-0.37	-0.49	-0.1	-0.51	0.15
Retained Earnings	0.93	0.96	0.85	0.63	0.88	0.99	0.02		0.88	0.95	0.61	0.89	0.96	0.77	0.91	0.97	0.95	0.9	0.97	0.99	0.91	0.78	0.27	0.25	0.68	0.11
Cash	0.96	0.91	0.88	0.7	0.8	0.89	-0.4	0.88		0.95	0.54	1.0	0.94	0.89	0.85	0.9	0.93	0.89	0.95	0.87	0.98	0.82	0.33	0.26	0.82	-0.14
Non Current Assets Total	0.98	0.92	0.94	0.76	0.84	0.96	-0.25	0.95	0.95		0.55	0.96	0.99	0.89	0.85	0.97	0.96	0.93	0.99	0.94	0.98	0.9	0.41	0.18	0.83	0.02
Non Currrent Assets Other	0.48	0.63	0.41	0.13	0.61	0.57	0.18	0.61	0.54	0.55		0.53	0.56	0.44	0.7	0.54	0.54	0.55	0.58	0.59	0.48	0.35	-0.09	-0.08	0.32	-0.26
Cash And Short Term Investments	0.97	0.91	0.9	0.73	0.79	0.9	-0.39	0.89	1.0	0.96	0.53		0.95	0.9	0.84	0.92	0.93	0.9	0.96	0.89	0.99	0.84	0.37	0.27	0.83	-0.07
Net Receivables	0.98	0.94	0.95	0.75	0.89	0.98	-0.18	0.96	0.94	0.99	0.56	0.95		0.88	0.86	0.99	0.97	0.95	0.99	0.97	0.97	0.9	0.42	0.23	0.78	0.03
Common Stock Shares Outstanding	0.86	0.83	0.86	0.7	0.71	0.82	-0.36	0.77	0.89	0.89	0.44	0.9	0.88		0.74	0.85	0.82	0.82	0.86	0.8	0.9	0.83	0.47	0.07	0.81	-0.01
Non Current Liabilities Total	0.84	0.97	0.7	0.32	0.91	0.9	0.11	0.91	0.85	0.85	0.7	0.84	0.86	0.74		0.83	0.87	0.76	0.92	0.91	0.82	0.61	-0.07	0.22	0.58	-0.21
Inventory	0.96	0.92	0.95	0.77	0.85	0.99	-0.11	0.97	0.9	0.97	0.54	0.92	0.99	0.85	0.83		0.95	0.94	0.97	0.98	0.95	0.9	0.46	0.25	0.76	0.18
Other Current Assets	0.96	0.95	0.89	0.7	0.93	0.96	-0.16	0.95	0.93	0.96	0.54	0.93	0.97	0.82	0.87	0.95		0.95	0.97	0.96	0.95	0.85	0.37	0.31	0.72	-0.07
Other Stockholder Equity	0.93	0.87	0.91	0.78	0.82	0.91	-0.25	0.9	0.89	0.93	0.55	0.9	0.95	0.82	0.76	0.94	0.95		0.92	0.9	0.93	0.86	0.56	0.26	0.73	0.06
Total Liab	0.98	0.97	0.91	0.67	0.9	0.98	-0.15	0.97	0.95	0.99	0.58	0.96	0.99	0.86	0.92	0.97	0.97	0.92		0.97	0.97	0.85	0.3	0.25	0.78	-0.03
Property Plant And Equipment Gross	0.94	0.97	0.88	0.63	0.91	1.0	0.04	0.99	0.87	0.94	0.59	0.89	0.97	0.8	0.91	0.98	0.96	0.9	0.97		0.91	0.81	0.3	0.29	0.67	0.1
Total Current Assets	0.99	0.91	0.94	0.78	0.8	0.93	-0.37	0.91	0.98	0.98	0.48	0.99	0.97	0.9	0.82	0.95	0.95	0.93	0.97	0.91		0.89	0.44	0.27	0.85	0.02
Accounts Payable	0.88	0.73	0.98	0.9	0.73	0.84	-0.37	0.78	0.82	0.9	0.35	0.84	0.9	0.83	0.61	0.9	0.85	0.86	0.85	0.81	0.89		0.66	0.2	0.79	0.13
Short Term Debt	0.41	0.16	0.61	0.86	0.13	0.33	-0.49	0.27	0.33	0.41	-0.09	0.37	0.42	0.47	-0.07	0.46	0.37	0.56	0.3	0.3	0.44	0.66		0.09	0.46	0.47
Other Assets	0.38	0.29	0.26	0.17	0.29	0.29	-0.1	0.25	0.26	0.18	-0.08	0.27	0.23	0.07	0.22	0.25	0.31	0.26	0.25	0.29	0.27	0.2	0.09		0.03	0.18
Common Stock Total Equity	0.8	0.66	0.81	0.75	0.54	0.7	-0.51	0.68	0.82	0.83	0.32	0.83	0.78	0.81	0.58	0.76	0.72	0.73	0.78	0.67	0.85	0.79	0.46	0.03		0.01
Short Term Investments	0.05	-0.08	0.16	0.32	-0.23	0.13	0.15	0.11	-0.14	0.02	-0.26	-0.07	0.03	-0.01	-0.21	0.18	-0.07	0.06	-0.03	0.1	0.02	0.13	0.47	0.18	0.01

Click cells to compare fundamentals

Repligen Account Relationship Matchups

Repligen fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.9B	2.4B	2.5B	2.8B	2.8B	3.0B
Short Long Term Debt Total	275.4M	366.1M	423.0M	711.8M	818.6M	859.5M
Other Current Liab	36.3M	70.5M	63.3M	46.4M	53.2M	55.9M
Total Current Liabilities	319.0M	375.3M	404.2M	158.2M	164.9M	173.2M
Total Stockholder Equity	65.8M	1.8B	397.3M	2.0B	2.3B	2.4B
Property Plant And Equipment Net	92.0M	226.5M	315.7M	323.0M	371.4M	390.0M
Net Debt	(441.9M)	(237.8M)	(100.5M)	(39.5M)	(35.6M)	(37.3M)
Retained Earnings	65.8M	194.1M	397.3M	438.8M	504.7M	529.9M
Cash	717.3M	603.8M	523.5M	751.3M	864.0M	907.2M
Non Current Assets Total	1.0B	1.4B	1.5B	1.7B	1.7B	1.8B
Non Currrent Assets Other	573K	615K	815K	1.3M	7.7M	8.1M
Cash And Short Term Investments	717.3M	603.8M	623.8M	751.3M	864.0M	907.2M
Net Receivables	71.4M	117.4M	116.2M	124.2M	142.8M	149.9M
Common Stock Shares Outstanding	53.9M	57.3M	57.5M	56.4M	64.8M	68.1M
Liabilities And Stockholders Equity	439.5M	2.4B	1.0B	2.8B	2.8B	3.0B
Non Current Liabilities Total	54.8M	233.0M	209.8M	695.0M	799.3M	839.3M
Inventory	95.0M	184.5M	238.3M	202.3M	232.7M	244.3M
Other Current Assets	18.7M	25.9M	19.8M	33.2M	33.5M	35.2M
Other Stockholder Equity	1.5B	1.6B	1.5B	1.6B	1.8B	1.9B
Total Liab	373.7M	608.3M	614.0M	853.2M	866.3M	909.7M
Property Plant And Equipment Gross	92.0M	297.2M	408.0M	451.7M	519.4M	545.4M
Total Current Assets	902.4M	931.7M	998.1M	1.1B	1.1B	1.2B
Accumulated Other Comprehensive Income	2.1M	(16.9M)	(34.4M)	(37.4M)	(33.7M)	(32.0M)
Accounts Payable	16.9M	36.2M	27.6M	19.6M	22.5M	23.6M
Short Term Debt	249.0M	263.6M	291.6M	75.1M	86.3M	99.8M
Other Assets	28.2M	2.5M	1.7M	6.5M	5.8M	6.1M
Common Stock Total Equity	521K	548K	553K	556K	639.4K	389.2K
Common Stock	548K	553K	556K	558K	641.7K	406.8K
Property Plant Equipment	48.5M	66.9M	125.0M	190.7M	219.3M	230.2M
Other Liab	32.3M	28.4M	130.5M	78.4M	90.1M	94.6M
Current Deferred Revenue	15.3M	14.8M	19.3M	10.3M	11.8M	12.4M
Good Will	618.3M	860.4M	855.5M	987.1M	1.1B	1.2B
Intangible Assets	287.1M	337.3M	353.7M	400.5M	460.6M	483.6M
Net Tangible Assets	378.8M	623.7M	552.4M	701.5M	806.7M	847.1M
Retained Earnings Total Equity	5.8M	65.8M	194.1M	397.3M	456.9M	479.7M
Capital Surpluse	1.1B	1.5B	1.6B	1.5B	1.8B	1.9B

Pair Trading with Repligen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Repligen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Repligen Stock

0.9

Agilent Technologies Earnings Call This Week

Pair Corr

Moving against Repligen Stock

0.54	ERAS	Erasca Inc	Pair Corr
0.43	EWTX	Edgewise Therapeutics Earnings Call This Week	Pair Corr
0.35	DSGN	Design Therapeutics	Pair Corr
0.34	VRDN	Viridian Therapeutics Earnings Call Next Week	Pair Corr

The ability to find closely correlated positions to Repligen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Repligen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Repligen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Repligen to buy it.

The correlation of Repligen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Repligen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Repligen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Repligen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:

How To Invest In Repligen

Details

Is Repligen Stock a good investment?

Details

What is Repligen's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.83)

Earnings Share

(0.03)

Revenue Per Share

11.338

Quarterly Revenue Growth

0.097

Return On Assets

0.006

The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Repligen Accounts Payable vs Property Plant And Equipment Gross Analysis

Accounts Payable vs Property Plant And Equipment Gross

Accounts Payable vs Property Plant And Equipment Gross Correlation Analysis

Correlation Coefficient

Accounts Payable

Property Plant And Equipment Gross

Repligen fundamental ratios Correlations

Repligen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Repligen fundamental ratios Accounts

Pair Trading with Repligen

Moving together with Repligen Stock

Moving against Repligen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Property Plant And Equipment Net
Inventory	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Retained Earnings

Net Debt	- 0.54	Total Current Liabilities
Common Stock Total Equity	- 0.51	Net Debt
Short Term Debt	- 0.49	Net Debt
Cash	- 0.4	Net Debt
Cash And Short Term Investments	- 0.39	Net Debt
Accounts Payable	- 0.37	Net Debt